Correlation Between Anavex Life and 94973VAT4
Specify exactly 2 symbols:
By analyzing existing cross correlation between Anavex Life Sciences and ELV 58 15 AUG 40, you can compare the effects of market volatilities on Anavex Life and 94973VAT4 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anavex Life with a short position of 94973VAT4. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anavex Life and 94973VAT4.
Diversification Opportunities for Anavex Life and 94973VAT4
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Anavex and 94973VAT4 is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Anavex Life Sciences and ELV 58 15 AUG 40 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ELV 58 15 and Anavex Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anavex Life Sciences are associated (or correlated) with 94973VAT4. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ELV 58 15 has no effect on the direction of Anavex Life i.e., Anavex Life and 94973VAT4 go up and down completely randomly.
Pair Corralation between Anavex Life and 94973VAT4
Given the investment horizon of 90 days Anavex Life is expected to generate 1.74 times less return on investment than 94973VAT4. In addition to that, Anavex Life is 1.95 times more volatile than ELV 58 15 AUG 40. It trades about 0.02 of its total potential returns per unit of risk. ELV 58 15 AUG 40 is currently generating about 0.07 per unit of volatility. If you would invest 9,748 in ELV 58 15 AUG 40 on November 2, 2024 and sell it today you would earn a total of 1,111 from holding ELV 58 15 AUG 40 or generate 11.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 15.38% |
| Values | Daily Returns |
Anavex Life Sciences vs. ELV 58 15 AUG 40
Performance |
| Timeline |
| Anavex Life Sciences |
| ELV 58 15 |
Anavex Life and 94973VAT4 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anavex Life and 94973VAT4
The main advantage of trading using opposite Anavex Life and 94973VAT4 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anavex Life position performs unexpectedly, 94973VAT4 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 94973VAT4 will offset losses from the drop in 94973VAT4's long position.| Anavex Life vs. Cassava Sciences | Anavex Life vs. INmune Bio | Anavex Life vs. Biovie Inc | Anavex Life vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |